22 June 2022Jurisdiction reports
Australia: CAR-T cell therapy patent disputes
Chimeric Antigen Receptor (CAR)-T cell therapy is a pioneering technology that is successfully changing the way we think about the treatment of cancer, in particular blood cancers. A number of CAR-T cell therapies have been approved in the US, Europe and Australia.
